EAM
Erste Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.8M | Buy |
201,100
+36,700
| +22% | +$11.1M | 0.51% | 42 |
|
|
2025
Q1 | $54.4M | Hold |
164,400
| – | – | 0.7% | 37 |
|
|
2024
Q4 | $51.3M | Sell |
164,400
-70,000
| -30% | -$21.8M | 0.63% | 40 |
|
|
2024
Q3 | $49.7M | Sell |
234,400
-10,980
| -4% | -$2.33M | 0.6% | 44 |
|
|
2024
Q2 | $68.9M | Sell |
245,380
-5,245
| -2% | -$1.47M | 0.91% | 25 |
|
|
2024
Q1 | $66.6M | Sell |
250,625
-74,375
| -23% | -$19.8M | 0.91% | 25 |
|
|
2023
Q4 | $75.3M | Buy |
325,000
+74,600
| +30% | +$17.3M | 1.1% | 13 |
|
|
2023
Q3 | $36.7M | Buy |
250,400
+239,400
| +2,176% | +$35.1M | 0.63% | 48 |
|
|
2023
Q2 | $2.42M | Hold |
11,000
| – | – | 0.04% | 265 |
|
|
2023
Q1 | $2.58M | Hold |
11,000
| – | – | 0.05% | 270 |
|
|
2022
Q4 | $3.26M | Buy |
+11,000
| New | +$3.26M | 0.07% | 244 |
|